Drug Shortage Report for APO-NAPROXEN

Last updated on 2018-04-05 History
Report ID 37971
Drug Identification Number 00522651
Brand name APO-NAPROXEN
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-01
Actual start date 2018-02-19
Estimated end date 2018-04-16
Actual end date 2018-04-04
Shortage status Resolved
Updated date 2018-04-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-04-05 French Compare
v5 2018-04-05 English Compare
v4 2018-02-21 French Compare
v3 2018-02-21 English Compare
v2 2018-02-01 French Compare
v1 2018-02-01 English Compare

Showing 1 to 6 of 6